CASRdb: A Publicly Accessible Comprehensive Database for Disease-Associated Calcium-Sensing Receptor Variants
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae769 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Nipith Charoenngam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Receptors, Calcium-Sensing, Hypercalcemia, Databases, Genetic, Hypoparathyroidism. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Context
Genetic testing of the calcium-sensing receptor (CASR) gene is crucial for confirming diagnoses of familial hypocalciuric hypercalcemia type I (FHH1) and autosomal dominant hypocalcemia type I (ADH1). Therefore, we created a publicly accessible comprehensive database of the disease-causing variants of the CASR gene. Evidence Acquisition We used 2 sources for variant reports: (1) we conducted a systematic review in the Embase and PubMed databases from inception to March 2023, using search strategies associated with CASR. We identified all articles reporting CASR variants associated with disorders of calcium metabolism. (2) Additionally, data associated with pathogenic (P) or likely pathogenic (LP) variants in the ClinVar and LOVD databases were retrieved. Benign or likely benign variants were excluded. Variants of uncertain significance (VUS) were included only if they were reported in the literature. We generated a library of CASR variants associated with phenotypes, which has been made available on a website. Evidence Synthesis We identified a total of 498 variants, of which 121 (24.3%) were associated with ADH1 and 377 (75.7%) with FHH1. Most included variants were identified from the literature (117 activating and 352 inactivating variants), and the majority of these were not documented in ClinVar/LOVD (73/117, 62.4% activating variants; 207/352, 58.8% inactivating variants).
Conclusion
We developed CASRdb, a database that compiles information on all CASR variants associated with disorders of calcium metabolism from existing literature and genomic databases. Our database stands out due to the substantially higher number of disease-associated variants it contains, highlighting its comprehensive nature. The website is available at http://casrdb.mgh.harvard.edu.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- Department of Medicine, Jefferson Einstein Hospital, Philadelphia, PA 19141, USA.
ORCID-Profile: Nipith Charoenngam, Michael Mannstadt
Zitieren
APA
Charoenngam, N., Wattanachayakul, P., & Mannstadt, M. (2025). CASRdb: A Publicly Accessible Comprehensive Database for Disease-Associated Calcium-Sensing Receptor Variants. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae769
Vancouver
Charoenngam N, Wattanachayakul P, Mannstadt M. CASRdb: A Publicly Accessible Comprehensive Database for Disease-Associated Calcium-Sensing Receptor Variants. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae769
BibTeX
@article{Charoenngam2025,
author = {Charoenngam, Nipith and Wattanachayakul, Phuuwadith and Mannstadt, Michael},
title = {CASRdb: A Publicly Accessible Comprehensive Database for Disease-Associated Calcium-Sensing Receptor Variants},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae769}
}
EUVIMED